Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
September 2, 2008
Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions
Lindsay S Wilson, Hisham S Elbatarny, Scott W Crawley, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
January 1, 2016
Leptin influences the excitability of area postrema neurons
Pauline M Smith, Paulina Brzezinska, Fabien Hubert, et al.
Circulation Research
|
August 25, 2007
Both protein kinase A and exchange protein activated by cAMP coordinate adhesion of human vascular endothelial cells
Stuart J Netherton, Jayda A Sutton, Lindsay S Wilson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 7, 2005
Inhibition of phosphodiesterase 5 selectively reverses nitrate tolerance in the venous circulation
Jeffery D MacPherson, Timothy D Gillespie, Heather A Dunkerley, et al.
European Journal of Pharmacology
|
January 9, 2007
Adiponectin, ghrelin, and leptin differentially influence human platelet and human vascular endothelial cell functions: implication in obesity-associated cardiovascular diseases
Hisham S Elbatarny, Stuart J Netherton, Jeffrey D Ovens, et al.
Molecular Pharmacology
|
April 19, 2002
Reduced phosphodiesterase 3 activity and phosphodiesterase 3A level in synthetic vascular smooth muscle cells: implications for use of phosphodiesterase 3 inhibitors in cardiovascular tissues
Heather A Dunkerley, Douglas G Tilley, Daniel Palmer, et al.
Cellular Signalling
|
November 19, 2023
Phosphodiesterase 4 activity uniquely regulates ciliary cAMP-dependent 3T3-L1 adipogenesis
Mikayla R Erdelsky, Sarah A Groves, Charmi Shah, et al.
The Journal of Biological Chemistry
|
January 27, 2007
Protein kinase A phosphorylation of human phosphodiesterase 3B promotes 14-3-3 protein binding and inhibits phosphatase-catalyzed inactivation
Daniel Palmer, Sandra L Jimmo, Daniel R Raymond, et al.
Molecular Pharmaceutics
|
February 14, 2020
Liquid Degradable Poly(trimethylene-carbonate-<i>co</i>-5-hydroxy-trimethylene carbonate): An Injectable Drug Delivery Vehicle for Acid-Sensitive Drugs
Sara Mohajeri, Fei Chen, Mitchell de Prinse, et al.
World Journal of Urology
|
March 3, 2012
Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer
Thomas K Hamilton, Nianping Hu, Klodiana Kolomitro, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Proceedings of the National Academy of Sciences of the United States of America
|
September 2, 2008
Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions
Lindsay S Wilson, Hisham S Elbatarny, Scott W Crawley, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
January 1, 2016
Leptin influences the excitability of area postrema neurons
Pauline M Smith, Paulina Brzezinska, Fabien Hubert, et al.
Circulation Research
|
August 25, 2007
Both protein kinase A and exchange protein activated by cAMP coordinate adhesion of human vascular endothelial cells
Stuart J Netherton, Jayda A Sutton, Lindsay S Wilson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 7, 2005
Inhibition of phosphodiesterase 5 selectively reverses nitrate tolerance in the venous circulation
Jeffery D MacPherson, Timothy D Gillespie, Heather A Dunkerley, et al.
European Journal of Pharmacology
|
January 9, 2007
Adiponectin, ghrelin, and leptin differentially influence human platelet and human vascular endothelial cell functions: implication in obesity-associated cardiovascular diseases
Hisham S Elbatarny, Stuart J Netherton, Jeffrey D Ovens, et al.
Molecular Pharmacology
|
April 19, 2002
Reduced phosphodiesterase 3 activity and phosphodiesterase 3A level in synthetic vascular smooth muscle cells: implications for use of phosphodiesterase 3 inhibitors in cardiovascular tissues
Heather A Dunkerley, Douglas G Tilley, Daniel Palmer, et al.
Cellular Signalling
|
November 19, 2023
Phosphodiesterase 4 activity uniquely regulates ciliary cAMP-dependent 3T3-L1 adipogenesis
Mikayla R Erdelsky, Sarah A Groves, Charmi Shah, et al.
The Journal of Biological Chemistry
|
January 27, 2007
Protein kinase A phosphorylation of human phosphodiesterase 3B promotes 14-3-3 protein binding and inhibits phosphatase-catalyzed inactivation
Daniel Palmer, Sandra L Jimmo, Daniel R Raymond, et al.
Molecular Pharmaceutics
|
February 14, 2020
Liquid Degradable Poly(trimethylene-carbonate-<i>co</i>-5-hydroxy-trimethylene carbonate): An Injectable Drug Delivery Vehicle for Acid-Sensitive Drugs
Sara Mohajeri, Fei Chen, Mitchell de Prinse, et al.
World Journal of Urology
|
March 3, 2012
Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer
Thomas K Hamilton, Nianping Hu, Klodiana Kolomitro, et al.
Page
of 5